ARTV
Artiva Biotherapeutics, Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P. bought $456K of Artiva Biotherapeutics, Inc.
Director
Bought$455,726
$9.96Price
45,768Shares
0%Stake
What ARTV did for a copier
- $1,000 copied at Mon, Aug 3 open, $10.00
- $860
- S&P 500, same days
- +0.6%
Measured over 30 trading days, to the Sep 16 close.
RA CAPITAL MANAGEMENT, L.P.'s record
64 other buys with 3 months of prices since 2016: on average −0.2% against the S&P 500, and 23 of 64 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jul 29. Filed Fri, Jul 31, 5:13 PM ET, after the close. Returns use the Aug 3 open and the Sep 16 close. Not investment advice.